Metastatic Malignant Neoplasm to the Leptomeninges Terminated Phase 1 Trials for RTA 744 (DB05920)

Also known as: Leptomeningeal Metastasis / Neoplastic Meningitis / Leptomeningeal Metastases / Metastatic Malignant Neoplasm in the Leptomeninges / Leptomeningeal Disease (LMD) / Leptomeningeal Disease / Lymphomatous meningitis / Leptomeningeal Carcinomatosis / Metastatic malignant neoplasm to leptomeninges (disorder) / Lymphomatous meningitis (disorder) / Malignant meningitis (disorder) / Leptomeningeal Neoplasms / Meningeal dissemination / Metastases to meninges / Meningeal Carcinomatosis

IndicationStatusPhase
DBCOND0057483 (Metastatic Malignant Neoplasm to the Leptomeninges)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00512460RTA 744 Injection in Patients With Leptomeningeal DiseaseTreatment
NCT00527410A Safety Study of RTA 744 in Recurrent, Progressive or Refractory Neoplastic MeningitisTreatment